Gentium SpA (GENT) Scheduled to Post Quarterly Earnings on Thursday
Gentium SpA (NASDAQ:GENT) will be posting its quarterly earnings results on Thursday, October 31st. Investors that wish to register for the company’s conference call can do so using this link.
Gentium SpA (NASDAQ:GENT) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.16 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.02 by $0.14. On average, analysts expect Gentium SpA to post $0.45 EPS for the current fiscal year and $1.36 EPS for the next fiscal year.
Shares of Gentium SpA (NASDAQ:GENT) opened at 37.88 on Wednesday. Gentium SpA has a 1-year low of $6.96 and a 1-year high of $22.40. The stock has a 50-day moving average of $17.93 and a 200-day moving average of $10.6. The company has a market cap of $574.8 million and a price-to-earnings ratio of 133.32.
Several analysts have recently commented on the stock. Analysts at Brean Capital reiterated a “buy” rating on shares of Gentium SpA in a research note to investors on Tuesday, October 22nd. On the ratings front, analysts at Zacks upgraded shares of Gentium SpA from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, October 16th. They now have a $30.50 price target on the stock. Finally, analysts at Zacks reiterated a “hold” rating on shares of Gentium SpA in a research note to investors on Monday, October 7th. They now have a $23.00 price target on the stock.
Gentium S.p.A. is a biopharmaceutical company focused on the development and manufacture of defibrotide, a drug based on single-stranded deoxyribonucleic acid (NASDAQ:GENT) derived from pig intestines.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.